Reversibility of adverse, calcineurin-dependent cardiac remodeling (Q35189672)

7 August 2017

title

Reversibility of adverse, calcineurin-dependent cardiac remodeling (English)

1 reference

7 August 2017

Jeff M Berry

1

1 reference

7 August 2017

Vien Le

2

1 reference

7 August 2017

David Rotter

3

1 reference

7 August 2017

Pavan K Battiprolu

4

1 reference

7 August 2017

Bennett Grinsfelder

5

1 reference

7 August 2017

Paul Tannous

6

1 reference

7 August 2017

Jana S Burchfield

7

1 reference

7 August 2017

Michael Czubryt

8

1 reference

7 August 2017

Johannes Backs

9

1 reference

7 August 2017

Eric N Olson

10

1 reference

7 August 2017

Beverly A Rothermel

11

1 reference

7 August 2017

Joseph A Hill

12

1 reference

7 August 2017

publication date

23 June 2011

1 reference

7 August 2017

1 reference

7 August 2017

volume

109

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

407-417

1 reference

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Cardiac autophagy is a maladaptive response to hemodynamic stress

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Regulation of cardiac hypertrophy by intracellular signalling pathways

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Controversies in ventricular remodelling

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Does load-induced ventricular hypertrophy progress to systolic heart failure?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

The effect of cardiac resynchronization on morbidity and mortality in heart failure

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Hypertrophy of the heart: a new therapeutic target?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

The role of modulatory calcineurin-interacting proteins in calcineurin signaling

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Prognostic significance of left ventricular mass change during treatment of hypertension

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

The progression from hypertension to congestive heart failure

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164792

Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition

27 September 2018

1 reference

12 December 2020

Calcineurin and human heart failure

1 reference

12 December 2020

The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid

1 reference

12 December 2020

Physiological growth synergizes with pathological genes in experimental cardiomyopathy

1 reference

12 December 2020

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

1 reference

12 December 2020

The transition from hypertrophy to failure: how certain are we?

1 reference

12 December 2020

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis

1 reference

12 December 2020

Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium

1 reference

12 December 2020

Cardiac hypertrophy is not a required compensatory response to short-term pressure overload

1 reference

12 December 2020

Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles

1 reference

12 December 2020

Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure

1 reference

12 December 2020

Accuracy of echocardiographic estimates of left ventricular mass in mice

1 reference

12 December 2020

MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction

1 reference

12 December 2020

Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study

1 reference

12 December 2020

10.1161/CIRCRESAHA.110.228452

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference